- Associated Press - Monday, February 13, 2017

RICHMOND, Va. (AP) - Legislation that prohibits health insurers from holding proton radiation cancer therapy to a higher standard of clinical effectiveness than other radiation treatments is advancing in the General Assembly.

A Senate committee approved the measure Monday. It has already passed the House of Delegates by a wide margin.

Proton therapy is a highly targeted, FDA-approved form of radiation that’s used to treat a variety of cancers while sparing surrounding healthy tissue, resulting in fewer side effects.

The bill’s sponsor, Del. David Yancey, says lawmakers in Oklahoma approved a similar bill in 2015.

Supporters included cancer patients and people whose relatives died of cancer.

A representative of the Virginia Association of Health Plans says proton therapy isn’t evaluated differently but studies have shown it’s not as effective for certain types of cancers.

Sign up for Daily Newsletters

Manage Newsletters

Copyright © 2019 The Washington Times, LLC.

Please read our comment policy before commenting.


Click to Read More and View Comments

Click to Hide